Emerging Clinical Evidence on Left Atrial Appendage Closure: A Case-based Discussion

Emerging Clinical Evidence on Left Atrial Appendage Closure: A Case-based Discussion

Live case with WATCHMAN FLX guided by intracardiac echocardiography (ICE)

Tuesday 29th September 2020
@ 16:30 (CEST)

Reserve Your Seat for this event.

 

LAA closure (LAAC) is a proven alternative to oral anticoagulation for preventing stroke in patients with non-valvular AF. In the era of NOACs the clinical evidence is also emerging. Join the panelists to discuss the implications of current and future trials on clinical practice. A live case from the University Clinic Aarhus, Denmark will focus on intracardiac echocardiography (ICE) to guide the LAA closure procedure with the next generation device WATCHMAN FLX.

 

Moderator:

Prof Tim Betts, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, UK

 

Co-moderator:

Dr Caroline Kleinecke, Clinic Waldshut-Tiengen, Germany

 

Speaker:

Prof Ignacio Cruz Gonzalez, University Hospital of Salamanca, Spain

 

Prof Jens Erik Nielsen-Kudsk, Aarhus University, Aarhus, Denmark

 

Prof Henning Ebelt, Catholic Hospital 'St Johann Nepomuk', Erfurt, Germany

 

Prof Marek Grygier, Poznan University of Medical Sciences, Poznan, Poland

 

  • Discuss the emerging evidence for the LAA closure therapy in the era of NOACs
  • Follow a live case with WATCHMAN FLX guided by ICE imaging
  • Learn how new workstreams with ICE can reduce the need for General Anaesthesia
  • Understand the benefits of combined procedures (AF Ablation + LAA closure) for patients
  • Learn about the trial design and endpoints of the OPTION trial and discuss the implication on clinical practice.
  • Understand how the new implantation technique of WATCHMAN FLX can optimize procedural results
  • Interventional Cardiologists and Electrophysiologists who would like to learn more about the growing evidence for the LAA closure therapy with WATCHMAN FLX
  • Non-invasive Cardiologists with an interest in the clinical evidence and the implications for the LAA closure therapy
 
This webinar is supported by: